Van Eck Associates Corp Sanofi Transaction History

Van Eck Associates Corp

$80.1 Billion
Q3 2024

A detailed history of Van Eck Associates Corp transactions in Sanofi stock. As of the latest transaction made, Van Eck Associates Corp holds 561,036 shares of SNY stock, worth $26.9 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

561,036

Previous 562,029 0.18%

Holding current value

$26.9 Million

Previous $27.3 Million 8.81%

% of portfolio

0.04%

Previous 0.04%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$48.54 - $58.53 $48,200 - $58,120	-993 Reduced 0.18%	561,036 $29.7 Million
Q2 2024 Jul 31, 2024	BUY	$45.39 - $50.36 $1.95 Million - $2.16 Million	42,961 Added 8.28%	562,029 $27.3 Million
Q1 2024 Apr 30, 2024	BUY	$45.75 - $52.48 $5.38 Million - $6.18 Million	117,694 Added 29.32%	519,068 $25.2 Million
Q4 2023 Feb 05, 2024	SELL	$43.13 - $54.79 $329,211 - $418,212	-7,633 Reduced 1.87%	401,374 $20 Million
Q3 2023 Nov 08, 2023	BUY	$50.95 - $55.2 $1.98 Million - $2.15 Million	38,926 Added 10.52%	409,007 $21.9 Million
Q2 2023 Aug 03, 2023	BUY	$50.45 - $57.18 $1.63 Million - $1.85 Million	32,278 Added 9.56%	370,081 $19.9 Million
Q1 2023 May 03, 2023	SELL	$45.86 - $54.45 $9.6 Million - $11.4 Million	-209,228 Reduced 38.25%	337,803 $18.4 Million
Q4 2022 Feb 08, 2023	SELL	$38.86 - $48.55 $2.54 Million - $3.17 Million	-65,364 Reduced 10.67%	547,031 $26.5 Million
Q3 2022 Oct 27, 2022	BUY	$37.22 - $100.5 $1.69 Million - $4.57 Million	45,464 Added 8.02%	612,395 $23.3 Million
Q2 2022 Aug 03, 2022	BUY	$48.99 - $57.46 $10.8 Million - $12.6 Million	219,580 Added 63.22%	566,931 $28.4 Million
Q1 2022 May 10, 2022	SELL	$48.48 - $53.65 $1.05 Million - $1.16 Million	-21,657 Reduced 5.87%	347,351 $17.8 Million
Q4 2021 Jan 26, 2022	BUY	$47.07 - $52.35 $1.76 Million - $1.96 Million	37,421 Added 11.29%	369,008 $18.5 Million
Q3 2021 Nov 03, 2021	BUY	$47.89 - $53.12 $5.16 Million - $5.72 Million	107,723 Added 48.12%	331,587 $16 Million
Q2 2021 Aug 10, 2021	SELL	$49.36 - $54.25 $876,682 - $963,534	-17,761 Reduced 7.35%	223,864 $11.8 Million
Q1 2021 May 13, 2021	SELL	$45.46 - $50.51 $556,248 - $618,040	-12,236 Reduced 4.82%	241,625 $12 Million
Q4 2020 Feb 09, 2021	BUY	$45.3 - $51.62 $1.14 Million - $1.29 Million	25,056 Added 10.95%	253,861 $12.3 Million
Q3 2020 Nov 12, 2020	SELL	$49.47 - $53.77 $3,957 - $4,301	-80 Reduced 0.03%	228,805 $11.5 Million
Q2 2020 Aug 10, 2020	BUY	$42.91 - $52.5 $1.8 Million - $2.2 Million	41,989 Added 22.47%	228,885 $11.7 Million
Q1 2020 May 12, 2020	SELL	$38.02 - $51.66 $559,806 - $760,641	-14,724 Reduced 7.3%	186,896 $8.17 Million
Q4 2019 Feb 13, 2020	BUY	$44.25 - $50.86 $1.59 Million - $1.83 Million	35,970 Added 21.71%	201,620 $10.1 Million
Q3 2019 Nov 08, 2019	SELL	$40.34 - $46.64 $1.33 Million - $1.54 Million	-32,952 Reduced 16.59%	165,650 $7.68 Million
Q2 2019 Aug 07, 2019	SELL	$40.43 - $44.3 $662,607 - $726,032	-16,389 Reduced 7.62%	198,602 $8.59 Million
Q1 2019 May 13, 2019	SELL	$40.83 - $45.43 $2.49 Million - $2.78 Million	-61,084 Reduced 22.13%	214,991 $9.52 Million
Q4 2018 Feb 12, 2019	SELL	$41.48 - $45.59 $1.45 Million - $1.6 Million	-35,016 Reduced 11.26%	276,075 $12 Million
Q3 2018 Nov 13, 2018	SELL	$40.0 - $44.84 $2 Million - $2.25 Million	-50,104 Reduced 13.87%	311,091 $13.9 Million
Q2 2018 Aug 13, 2018	BUY	$37.63 - $41.22 $1.78 Million - $1.95 Million	47,420 Added 15.11%	361,195 $14.5 Million
Q1 2018 May 11, 2018	BUY	$38.98 - $45.76 $61,393 - $72,072	1,575 Added 0.5%	313,775 $12.6 Million
Q4 2017 Feb 12, 2018	BUY	$42.86 - $50.61 $1.47 Million - $1.73 Million	34,208 Added 12.31%	312,200 $13.4 Million
Q3 2017 Nov 09, 2017	SELL	$47.04 - $50.34 $269,492 - $288,397	-5,729 Reduced 2.02%	277,992 $13.8 Million
Q2 2017 Aug 11, 2017	BUY	N/A	283,721	283,721 $13.6 Million

Others Institutions Holding SNY

# of Institutions

820

Shares Held

274M

Call Options Held

Put Options Held

1.9M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $120B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Account

Van Eck Associates Corp Sanofi Transaction History